Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation |
|---|
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
SARS-CoV2 or CoVid19 disease is a newly described pathology linked to a subtype of the coronavirus family identified in China in December 2019. This pathology can present multiple clinical facets, ranging from asymptomatic forms to more commonly critical pulmonary forms called "Acute Respiratory Distress Syndrome". The elderly population is more at risk for this infection due to the senescence of the immune system, co-morbidities and poly medications. They also often present a greater state of fragility. This study aims to report the epidemiology of the first 50 patients over 90 years of age hospitalized within the CHU Brugmann hospital.
Description: Age, sex, ethnicity
Measure: Demographic data Time: 5 minutesDescription: Smoking, Obesity, Diabetes, Arterial hypertension, Coronary pathology, Cerebrovascular disease, chronic renal failure, chronic obstructive pulmonary disease, Neoplasia, Autoimmune disease, Chronic liver disease
Measure: Comorbidities Time: 5 minutesDescription: CIRS-G quantifies burden of disease in elderly patients (comorbidity scale). Higher scores indicate higher severity (maximum score = 56 points).
Measure: Cumulative Illness Rating Scale-Geriatric (CIRS-G) Time: 5 minutesDescription: Under Chronic corticosteroid therapy or Immunosuppressive therapy
Measure: Treatments Time: 5 minutesDescription: Presence and date of first apparition: Fever, Cough, Dyspnea, Chest pain, Nausea or vomiting, Diarrhea, Fatigue, Anosmia, ageusia, inappetence, Confusion, Fall, Fracture
Measure: Signs and symptoms Time: 5 minutesDescription: Vital signs at hospital admission: Fever
Measure: Fever Time: 5 minutesDescription: Vital signs at hospital admission: Hypoxemia
Measure: Hypoxemia Time: 5 minutesDescription: Vital signs at hospital admission:Tachycardia
Measure: Tachycardia Time: 5 minutesDescription: Vital signs at hospital admission: Hypotension
Measure: Hypotension Time: 5 minutesDescription: Vital signs at hospital admission: Gasometry
Measure: Gasometry Time: 5 minutesDescription: Contact with confirmed covid person before admission, lives in a retirement home with other cases, Initial bacterial or viral co-infection, Bacterial or viral co-infection during the hospital stay
Measure: Infectious data Time: 5 minutesDescription: Blood count at hospital admission or first recorded
Measure: Blood count Time: 5 minutesDescription: Ionogram at hospital admission or first recorded
Measure: Ionogram Time: 5 minutesDescription: Liver function at hospital admission or first recorded
Measure: Liver function Time: 5 minutesDescription: Coagulation at hospital admission or first recorded
Measure: Coagulation Time: 5 minutesDescription: Renal function at hospital admission or first recorded
Measure: Renal function Time: 5 minutesDescription: Albumin at hospital admission or first recorded
Measure: Albumin Time: 5 minutesDescription: CRP at hospital admission or first recorded
Measure: CRP Time: 5 minutesDescription: Fibrinogen at hospital admission or first recorded
Measure: Fibrinogen Time: 5 minutesDescription: D-dimers
Measure: D-dimers at hospital admission or first recorded Time: 5 minutesDescription: NTproBNP at hospital admission or first recorded
Measure: NTproBNP Time: 5 minutesDescription: CK at hospital admission or first recorded
Measure: CK Time: 5 minutesDescription: Troponin at hospital admission or first recorded
Measure: Troponin Time: 5 minutesDescription: Ferritin at hospital admission or first recorded
Measure: Ferritin Time: 5 minutesDescription: Procalcitonin at hospital admission or first recorded
Measure: Procalcitonin Time: 5 minutesDescription: Highest rate of CRP, D-Dimers, Urea, Creatinin, Fibrinogen, CK, Troponins
Measure: Biology - highest rate Time: 5 minutesDescription: Lowest rate of hemoglobin, platelets, leucocytes, lymphocytes, albumin, Na+, K+
Measure: Biology - lowest rate Time: 5 minutesDescription: Percentage of pulmonary involvement on chest CT scan
Measure: Percentage of pulmonary involvement on chest CT scan Time: 5 minutesDescription: Number of pulmonary lobes affected
Measure: Number of pulmonary lobes affected Time: 5 minutesDescription: Type of lesions as reflected on the CT scan images: 'Ground glass' or 'Crazy paving'
Measure: Type of lesions Time: 5 minutesDescription: Need for oxygenotherapy (yes/no)
Measure: Need for oxygenotherapy Time: 5 minutesDescription: Means of ventilation
Measure: Means of ventilation Time: 5 minutesDescription: Hydroxychloroquine or Azithromycin
Measure: Treatment received Time: 5 minutesDescription: Length of ICU Stay
Measure: Length of ICU Stay Time: 5 minutesDescription: One of the following choices: death, went back home, went back to a retirement home, was placed in a revalidation unit.
Measure: Status at hospital exit Time: 5 minutesDescription: 28-day mortality after PCR / CT scan / diagnosis
Measure: Mortality Time: 5 minutesAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports